The endocannabinoid system (ECS) is a cell signaling network that keeps the body in a stable range. It runs on three parts: endocannabinoids the body makes on demand, receptors that receive them, and enzymes that clear them away. The ECS touches mood, appetite, sleep, pain, immune response, and memory. Its core job is homeostasis, which means it nudges a system back toward balance when stress, injury, or illness pushes it off course.

what are cb1 and cb2 receptors

The Three Core Components

  • Endocannabinoids. Anandamide (AEA) and 2-arachidonoylglycerol (2-AG) are the two best studied. Unlike hormones, they are not stored in advance. Cells build them on demand and they act near the cell that released them.
  • Receptors. CB1 sits mostly on neurons in the brain and central nervous system. CB2 sits mostly on immune cells and in peripheral tissue.
  • Enzymes. Fatty acid amide hydrolase (FAAH) breaks down anandamide. Monoacylglycerol lipase (MAGL) breaks down 2-AG. Together they end the signal.

How Signaling Works, Step by Step

  1. A stimulus arrives, such as stress, injury, or a change in neurotransmitter activity.
  2. A cell builds endocannabinoids from lipid precursors in its membrane.
  3. The endocannabinoids leave the cell and travel a short distance across the synapse.
  4. They bind CB1 or CB2 receptors on the neighboring cell.
  5. The receptor changes what that target cell does, which often dampens a signal that was running hot.
  6. FAAH and MAGL break the endocannabinoids down, and the signal stops.

This backward, on-demand pattern sets the ECS apart from most neurotransmitter systems. Endocannabinoids travel from the receiving cell back to the sending cell, so they work as a brake rather than a gas pedal.

endocannabinoid deficiency symptoms

CB1 and CB2: What Each Receptor Does

  • CB1 is one of the most abundant receptors in the brain. It shows up in the cortex, hippocampus, cerebellum, and basal ganglia, which is why ECS activity ties into memory, movement, and mood.
  • CB2 appears mainly on immune cells such as macrophages and microglia. It plays a larger role in inflammation and immune signaling than in immediate neuron firing.

Both receptors are G protein coupled. When an endocannabinoid binds one, it changes how much of a neurotransmitter the target cell releases, not whether the cell fires at all.

related article

Where the ECS Shows Up in the Body

  • Brain and nerves: memory, mood, pain perception, and stress response.
  • Digestive tract: gut motility, nausea, and appetite signaling.
  • Immune tissue: inflammation and immune cell activity.
  • Skin and connective tissue: wound response and local inflammation.
  • Metabolic tissue: fat storage, energy use, and blood sugar handling.

Phytocannabinoids and the ECS

Plant compounds can interact with this network in different ways. THC binds CB1 and CB2 receptors directly, which is why it produces psychoactive effects. CBD does not bind CB1 tightly. Research points to other routes, including slowing anandamide breakdown and acting at targets such as serotonin 5-HT1A receptors. That difference explains why THC and CBD feel so unlike each other even though both are called cannabinoids.

What is Anandamide in the Endocannabinoid System?

What This Means in Practice

A healthy ECS does not need boosting in the supplement sense. It responds to sleep, movement, diet, and stress load. If you use cannabis, knowing where THC and CBD act helps you predict effects: THC leans on CB1 in the brain, while CBD leans on enzyme and receptor pathways outside the classic CB1 lock and key.